News

January 7th, 2016Natixis Partners advised Omnes Capital, Parquest Capital and Vivalto with respect to the sale of Vivalto Santé to a consortium led by CDC International Capital together with Mubadala, MACSF and Vivalto

Vivalto Santé is one of the leading private hospitals groups in France with close to 1,000 health practitioners operating across 14 facilities and providing care to approximately 300,000 patients annually.

Established in 2009 by Daniel Caille through the acquisition of Brittany-based group Cliniques Privées Associées, supported by Omnes Capital and Parquest Capital, the group has grown organically, as well as through acquisitions, and expects to generate €330 million of revenues in 2015. The Group’s unique model, known as the “third way", and based on its health practitioners’ participation in both the ownership and decision-making at Group level, has enjoyed remarkable success in terms of growth (tripling its turnover) and recognition of its medical excellence in the French national rankings such as CHP Saint Grégoire (Rennes) which has consistently been ranked #1 private hospital in France by the weekly magazine Le Point since 2010.

The new group of shareholders will enable Vivalto Santé to continue delivering on its strategy of growth and efficiency through further acquisitions of independent hospitals and small, regional hospital groups, as well as developing the Group’s international profile. 

 

‹ Back to news

M&A team:

Ludovic Tron
Managing Partner

Erwan Thébault
Director

Emilie Petit
Associate


Debt Advisory Team:

Philippe Charbonnier
Managing Director

Patrice Raulin
Director